This week’s policy blog includes federal and state updates on topics relevant to Colorado’s life sciences ecosystem:
- Reauthorization of SBIR/STTR Programs
- Colorado’s Budget Shortfall and Special Legislative Session
- Colorado PDAB’s Third Upper Payment Limit Rulemaking Hearing for Enbrel
Read to learn more about these important issues and how CBSA is engaging.
Reauthorization of SBIR/STTR Programs
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs help translate cutting-edge discoveries into real-world solutions, driving economic growth, creating jobs, and improving public health. As a one-pager from Biotechnology Innovation Organization (BIO) explains, the SBIR/STTR Programs provide early-stage, non-dilutive funding to support high-risk, high-reward research, bridging the early investment gap that can prevent breakthroughs from reaching patients. Through a three-phase process, these federal R&D programs help life sciences startups and small businesses develop and…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
